… structural correlates of SARS-CoV-2 neutralization, we solved eight new structures of distinct
COVID-19 human neutralizing antibodies 5 in complex with the SARS-CoV-2 spike trimer …

… RBD-specific monoclonal antibodies derived from single B cells from 8 individuals infected
with SARS-CoV-2. We identified antibodies that potently neutralize SARS-CoV-2; this activity …

… Age did not appear to compromise antibody responses, even … SARS-CoV-2 infection elicits
robust neutralizing antibody … that SARS-CoV-2 infection elicits robust neutralizing antibody …

… that have antibody-escape mutations and the potential for antibody-… representative
SARS-CoV-2 neutralizing antibodies that have … of COVID-19 preventive or therapeutic antibodies. …

… arms race between SARS-CoV-2 and human humoral immunity. Indeed, we showed that
Omicron would escape most of the SARS-CoV-2 neutralizing antibodies in this collection (…

… Our results also suggest that SARS-CoV-2 subspecies with the RBD mutations Y453F …
neutralizing monoclonal antibodies and 21 neutralizing antibodies in sera derived from COVID-19-…

… COVID-19 symptoms to determine the robustness and longevity of the anti–SARS-CoV-2
antibody response. They found that neutralizing antibody titers against the SARS-CoV-2 spike …

… coronavirus. Here we report the isolation of sixty-one SARS-CoV-2-neutralizing monoclonal
antibodies from five patients infected with SARS-CoV-2 and admitted to hospital with severe …

… phase 2 trial involving outpatients with recently diagnosed mild or moderate Covid-19, we
… to receive a single intravenous infusion of neutralizing antibody LY-CoV555 in one of three …

… -SARS-CoV-2 agents. However, the degree to which SARS-CoV-2 will adapt to evade
neutralizing antibodies … chimeric VSV/SARS-CoV-2 reporter virus, we show that functional SARS-…